Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients

被引：0
|
作者：
Beaumont, J.
Cella, D.
Hutson, T.
Bracarda, S.
Gruenwald, V.
Thompson, J.
Ravaud, A.
Urbanowitz, G.
Hollaender, N.
Motzer, R.
机构：
[1] Ctr Outcomes Res & Educ, Evanston, IL USA
[2] Ctr Outcomes Res & Educ, Chicago, IL USA
[3] US Oncol, Baylor Sammons Canc Ctr, Dallas, TX USA
[4] Azienda Osped, Perugia, Italy
[5] Hannover Med Sch, D-3000 Hannover, Germany
[6] Canc Care Alliance, Seattle, WA USA
[7] CHU Bordeaux, Hop St Andre, Bordeaux, France
[8] Novartis, Oncol, Florham Pk, NJ USA
[9] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17516
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Results from additional analyses of patient reported outcomes in RECORD-1-a randomized trial of everolimus with metastatic renal cell carcinoma patients
    Beaumont, J.
    Cella, D.
    Hollaender, N.
    Zheng, J.
    Baladi, J. F.
    Hutson, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 431 - 431
  • [2] Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes
    Cella, David
    CANCER TREATMENT REVIEWS, 2009, 35 (08) : 733 - 737
  • [3] Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
    Cella, D.
    Escudier, B.
    Rini, B.
    Chen, C.
    Bhattacharyya, H.
    Tarazi, J.
    Rosbrook, B.
    Kim, S.
    Motzer, R.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1571 - 1578
  • [4] Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
    D Cella
    B Escudier
    B Rini
    C Chen
    H Bhattacharyya
    J Tarazi
    B Rosbrook
    S Kim
    R Motzer
    British Journal of Cancer, 2013, 108 : 1571 - 1578
  • [5] Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial
    Cella, David
    Escudier, Bernard
    Tannir, Nizar M.
    Powles, Thomas
    Donskov, Frede
    Peltola, Katriina
    Schmidinger, Manuela
    Heng, Daniel Y. C.
    Mainwaring, Paul N.
    Hammers, Hans J.
    Lee, Jae Lyun
    Roth, Bruce J.
    Marteau, Florence
    Williams, Paul
    Baer, John
    Mangeshkar, Milan
    Scheffold, Christian
    Hutson, Thomas E.
    Pal, Sumanta
    Motzer, Robert J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 757 - +
  • [6] Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma
    Ristau, Benjamin T.
    Geynisman, Daniel M.
    EUROPEAN UROLOGY, 2017, 71 (02) : 210 - 212
  • [7] Using Electronic Patient-Reported Outcome Measures for Patients With Metastatic Renal Cell Carcinoma: A Narrative Review
    Minot, Lucie
    Javaugue, Vincent
    Arbutina, Marlene
    Emambux, Sheik
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2025, 29 (01) : E17 - E27
  • [8] Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer A Randomized Clinical Trial
    Basch, Ethan
    Schrag, Deborah
    Henson, Sydney
    Jansen, Jennifer
    Ginos, Brenda
    Stover, Angela M.
    Carr, Philip
    Spears, Patricia A.
    Jonsson, Mattias
    Deal, Allison M.
    Bennett, Antonia, V
    Thanarajasingam, Gita
    Rogak, Lauren J.
    Reeve, Bryce B.
    Snyder, Claire
    Bruner, Deborah
    Cella, David
    Kottschade, Lisa A.
    Perlmutter, Jane
    Geoghegan, Cindy
    Samuel-Ryals, Cleo A.
    Given, Barbara
    Mazza, Gina L.
    Miller, Robert
    Strasser, Jon F.
    Zylla, Dylan M.
    Weiss, Anna
    Blinder, Victoria S.
    Dueck, Amylou C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (24): : 2413 - 2422
  • [9] Patient reported outcomes in a phase 2 trial of SU11248 for metastatic renal cell carcinoma.
    Beaumont, J
    Cella, D
    Li, J
    Motzer, R
    Rini, B
    Michaelson, D
    Kim, S
    Baum, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 770S - 770S
  • [10] PATIENT-REPORTED OUTCOMES IN A PILOT RANDOMIZED TRIAL OF GENOME SEQUENCING
    Christensen, K. D.
    Phillips, K. A.
    McGuire, A. L.
    Green, R. C.
    VALUE IN HEALTH, 2018, 21 : S327 - S327
12345